Because of the disparity in fungal burden between the IL-22−/− and IL-23−/−, mainly in the primary site, the lungs (Figure 1N), we evaluate the impact of the infection in the lung integrity, and on the cytokine microenvironment of both lungs and brain (Figure 2). This evidence concerns the gene IL22 and infection.